A study, published in Journal of Digestive Disease, examined whether a new same-day, low-dose polyethylene glycol-based bowel preparation was both tolerable and effective for bowel preparation. Study ...

MAHWAH, N.J., March 10, 2025 /PRNewswire/ -- Glenmark Therapeutics Inc., USA (Glenmark) is pleased to announce the launch1 of Polyethylene Glycol 3350, Powder for Solution, 17 grams/capful (OTC); ...

Ani Pharmaceuticals announced that the Food and Drug Administration (FDA) has approved the Abbreviated New Drug Application (ANDA) for Polyethylene Glycol 3350 Powder for Oral Solution. Ani ...

Strides Pharma Science announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte.,Singapore, has received approval for Polyethylene Glycol 3350 and Electrolytes for Oral Solution ...

A process called PEGylation (covalent binding with polyethylene glycol, PEG) is frequently adopted to alter some characteristics of many proteins and drugs 2-4. PEG is a synthetic polymer composed of ...

According to Nielsen® syndicated data for the latest 52 weeks' period ending February 22, 2025, the MiraLAX® Powder for Solution, 17 grams (OTC) market 3 achieved annual sales of approximately $555.7 ...

Glenmark Therapeutics Inc., USA (Glenmark) announced the launch of polyethylene glycol 3350, powder for solution, 17 grams/capful (OTC); compare to the active ingredient in MiraLAX powder for solution ...